ZWZixu Wang

Zixu Wang

*This is an algorithmically generated author record based on publicly available information.

Zixu Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hotwiring integrin endocytosis acutely modulates cell interactions

    by Sahil Kamboj, Alphonse Boché, Anneline Moret, Zixu Wang, Carole Aimé, Rémy Agniel, Johanne Leroy-Dudal, Franck Carreiras, Olivier Gallet, Stephen J Royle, et al.

    Integrins are heterodimeric cell surface receptors that govern cell-cell interactions, which in turn can influence multiscale processes: cell migration, extracellular matrix remodeling and tissue formation. These processes occur over timescales which range from milliseconds to days. While various strategies exist to study integrin function across biological scales from cell to tissue, they are often chronic and fail to target specific cell-cell interactions acutely. We engineered cells to rapidly alter cell behavior by downregulating the surface population of α5β1 integrins through hot-wired clathrin-mediated endocytosis. This method allows for inducible, specific internalization of α5β1 integrins, achieving acute downregulation across various cell lines in 5-30 minutes. We show that induced internalization of α5β1 decreases the cell area, causes uptake of extracellular fibronectin, and decreases the rate of tumor spheroid compaction. This targeted control of multiscale processes by rapid downregulation of this important class of cell surface receptors demonstrates that hot-wired endocytosis is a useful tool to acutely modulate cell biology.


  • Open Access

    In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models

    by Elliot Lopez, Sahil Kamboj, Changchong Chen, Zixu Wang, Sabrina Kellouche, Johanne Leroy-Dudal, Franck Carreiras, Ambroise Lambert, Carole Aimé

    Ovarian cancer (OC) is a disease of major concern with a survival rate of about 40% at five years. This is attributed to the lack of visible and reliable symptoms during the onset of the disease, which leads over 80% of patients to be diagnosed at advanced stages. This implies that metastatic activity has advanced to the peritoneal cavity. It is associated with both genetic and phenotypic heterogeneity, which considerably increase the risks of relapse and reduce the survival rate. To understand ovarian cancer pathophysiology and strengthen the ability for drug screening, further development of relevant in vitro models that recapitulate the complexity of OC microenvironment and dynamics of OC cell population is required. In this line, the recent advances of tridimensional (3D) cell culture and microfluidics have allowed the development of highly innovative models that could bridge the gap between pathophysiology and mechanistic models for clinical research. This review first describes the pathophysiology of OC before detailing the engineering strategies developed to recapitulate those main biological features.